6/10/2016. Hui-Chun Hsu
|
|
- Laura Fowler
- 5 years ago
- Views:
Transcription
1 Hui-Chun Hsu PhD, RN, CDE Chief, Department of Diabetes Management Lee s Endocrinology Clinic Pingtung, Taiwan Disclosure to Participants Conflict of Interest (COI) and Financial Relationship Disclosures: Presenter: Hui-Chun Hsu, PhD, RD, CDE No COI/Financial Relationship to disclose Development of A Simplified Self- Reported Diabetic-Behavior Scoreboard as a Promising Assessment Tool to Key Diabetic Behavior Hsu H-C 1, An L-W 2, Lee Y-J, Wang R-H 3 1 Department of Internal Medicine, Lee s Endocrinology Clinic, Pingtung, Taiwan 2 Department of Medical Education, Beijing Ruijing Diabetes Hospital, Beijing , China 3 Department of Nursing, School of Nursing, Kaohsiung Medical University, Kaohsiung, 80317, Taiwan Diabetes Self- Management Education & Support, (DSME/S ) DSME/S is a complex and ongoing process Provide patients the knowledge and skill training Identifying the barriers Facilitate the problem-solving and coping skills It is effective at enhancing self-care behaviors and improving glycemic control. 2016/6/10 6 1
2 Assessment of DSME/S related behavior & risk factors The initial step for education, training & support. Provide subjective evidence to identify the problem/diagnosis and key etiology that could be modified by intervention procedure. Diabetic Behavior Hypoglycemia awareness & management skill Healthy eating Taking medication Being active Self -monitoring of blood glucose (SMBG) Psychological stress problem Quality of life Aim-(I) Diabetes Information & Management System 1. To construct a self-reported diabetes-related behavior dashboard for daily clinical practice Diabetes Self-Management Behavior Assessment Hypoglycemia Assessment Client History Medication History Physical & Laboratory Exam. Behavior Evaluation Risk Factor & Complication Assessment 2
3 Assessment of Diabetes Self Management Behavior 1st priority- Hypoglycemia awareness and skill of management Simple, accurate, quantifiable scale with reasonable reproducibility and precision Hypoglycemia Assessment Hyperglycemia Assessment Sick day management Skill Health Eating Being Active PAID-Chinese SF Taking Medicine SMBG Scoring Hsu HC, et al. J Nurs Res Sep;21(3): Scoring 3
4 Hsu HC, et al. J Nurs Res Sep;21(3): Hsu HC, et al. J Nurs Res Sep;21(3): WHO 5 well-being index-chinese Scoring WHO 5 well-being index Chinese WHO 5 well-being index Chinese PSQI 4
5 PSQI Risk Factor & Complication Assessment Assessment Hypoglycemia Assessment Diagnosis/Problem Intervention Re-Evaluation Behavior Evaluation Risk Factor & Complication Assessment Diabetes Self-Management Behavior Assessment Dashboard Validity test: Two professors of nursing, four endocrinologists, four certified diabetic educators, three Nutritionists and two diabetic patients were invited to assess the content validity. Results: Content validity index (CVI) :0.866~1.0 The process of inter-rater reliability assessment to : The test-retest reliability of intra-class correlation coefficient :
6 Operating Time 80% (n=8) of CDEs agreed Diabetic- Behavior Scoreboard is easy to assess diabetes behaviors. The mean of operating time was12.8 ±6.9 minutes per patients with type 2 diabetes Aim- (II) Clinical Application Patients: From August 2012 to August 2013 at, a total of 3,404 patients with type 2 diabetes mellitus were enrolled into in a specialized diabetic polyclinic. Subjects The exclusive criteria were age of 18 years or >80 years, being pregnant, having cognitive disabilities (dementia, mental retardation), or having a history of cerebrovascular disease. Patients were followed-up in the program for at least for 2 years were included in this clinical observational study. Subjects a comprehensive diabetic care program under the ADA diabetic practice guidelines covered by the National Health Insurance system In this comprehensive diabetic care program, patients were requested to return to the clinic every 3 months. Table 1. Clinical and biochemical characteristics and diabetes behavior scores of participants Variable Difference between Baseline (N=3,404) 12-Month follow-up (N=3,404) baseline and follow-up Range Mean (SD) Range Mean (SD) t Waist (cm) (10.4) (10.3) 2.7 (p=0.006) Waist-to-hip ratio (0.1) (0.1) 2.3 (p=0.023) Body mass index (kg/m 2 ) (4.3) (4.3) -4.2 (p<.0001) SBP (mmhg) (18) (19) -2.8 (p=0.005) DBP (mmhg) (13) (12.3) -4.7 (p<.0001) Fasting sugar (mg/dl) (51.7) (47.8) -0.0 (p=0.994) HBA1C (%) (1.4) (1.4) -5.0 (p<.0001) T-cholesterol (mg/dl) (34.7) (33.1) (p<.0001) Triglyceride (mg/dl) (117.2) (113.4) -0.2 (p=0.850) HDL-cholesterol (mg/dl) (14.4) (15.0) 0.5 (p=0.607) LDL-cholesterol (mg/dl) (27.8) (25.7) (p<.0001) Creatinine (mg/dl) (0.5) (0.6) 7.4 (p<.0001) egfr (23.6) (24.5) -5.1 (p<.0001) Table 1. Clinical and biochemical characteristics and diabetes behavior scores of participants Variable DBS per dimension Baseline 12-Month follow-up Difference between baseline and followup Range Mean (SD) Range Mean (SD) t Diet (2.3) (2.0) 7.2 (p<.0001) Exercise (2.8) (2.7) 3.7 (p=0.0002) Medication (1.5) (1.6) 0.1 (p=0.927) Monitoring (3.2) (3.2) -2.9 (p=0.004) PAID (6.0) (4.9) -11 (p<.0001) WHO 5 well-being index (3.8) (3.5) 2.0 (p=0.047) Total behavior score (5.9) (5.7) 2.7 (p=0.007) 6
7 Table 2. Correlations between baseline diabetes behavior scoreboard dimensions and health indicators A. Correlations between baseline diabetes behavior scoreboard dimensions and health indicators Variable HbA1c BMI Waist LDL-C Triglycerides MBP egfr Age Sex DM duration Education level Diet-b Exercise-b Medication-b Monitoring-b Total score of PAID-b Total score of WHO well-being index-b Total diabetic behavior score-b Table 2. Correlations between 12-month follow-up of diabetes behavior scoreboard dimensions and health indicators B. Correlations between 12-month follow-up of diabetes behavior scoreboard dimensions and health indicators Variable HbA1c BMI Waist LDL-C Triglycerides MBP egfr Age Sex DM duration Education level Diet-a Exercise-a Medication-a Monitoring-a Total score of PAID-a Total score of WHO well-being index-a Total diabetic behavior score-a Table 3. Linear regression analysis of variables associated with baseline HbA1c levels in subjects studied Baseline HbA1c levels Simple Multiple Variable β coefficient p value β coefficient p value Age < Sex Diabetes duration < <.0001 Education level BMI-b < Mean BP-b < Triglyceride-b < <.0001 LDL-cholesterol-b < <.0001 egfr-b Diet-b < <.0001 Exercise-b < Medication-b < Monitoring-b Total score of PAID-b < <.0001 Total score of WHO 5 wellbeing < index-b Total behavior score-b < Baseline Table 3. Linear regression analysis of variables associated with 12-month follow-up HbA1c levels in subjects studied 12-month follow-up HbA1c levels Simple Multiple Variable β coefficient p value β coefficient p value Age < Sex Diabetes duration < <.0001 Education level BMI-a < Mean BP-a < Triglyceride-a < <.0001 LDL-cholesterol-a < <.0001 egfr-a Diet-a < <.0001 Exercise-a < Medication-a < Monitoring-a < Total score of PAID-a < <.0001 Total score of WHO 5 wellbeing < index-a Total behavior score-a < < month follow up 7
8 Demographic character Age, Sex, Diabetic duration, Education level H 1 H 2 Diabetic-Behavior health eating, taking medication, exercise, blood glucose self-monitoring, psychologic behavior H3 H 4 Age Sex Education Duration (Diabetes) Demographic character *** 0.46*** Diabetic Behavior DM control HbA1c BMI MBP TG LDL Diabetes mellitus control BMI, B;ood pressure, HaA1C, LDL-Cholesterol, egfr WHO PAID Monitoring Medication Exercise Diet Figure 1. Theoretical model of diabetic behavior and diabetes mellitus control. Figure 2. Final model of diabetic behavior and diabetes mellitus control (baseline report). ***p < Table 4. Linear regression analysis of 12-month diabetes behavior scoreboard associated with difference in baseline and 12-month HbA1C levels in subjects studied Age 0.90 HbA1c 0.59 Sex Demographic BMI 0.09* DM control 0.46 character 0.18 Education MBP *** Duration 0.41*** 0.16 TG (Diabetes) LDL Diabetic Behavior WHO PAID Monitoring Medication Exercise Diet Figure 3. Final model of diabetic behavior and diabetes mellitus control (12-month follow-up report). *p<0.05, ***p < Simple Multiple Variable β coefficient p value β coefficient p value Age Sex Diabetes duration <.0001 Education level Baseline HbA1c < <.0001 Diet-d < Exercise-d Medication-d < Monitoring-d < Total score of PAID-d < Total score of WHO 5 well-being index-d < Total behavior score-d < <.0001 Summary 1. High Validity with 0.866~ Convenient, easy performed, time saving. 3. Self reported diabetes related behavior correlated with glycemic control status. Conclusion Diabetes Behavior Scoreboard a precise, convenient computer-based system to evaluate and follow the changes of diabetes related behavior in patients with T2DM 8
9 Diabetes life, Health life, Joyous life, Living more amazing Thank you 9
The Role of the Diabetes Educator within the Patient-Centered Medical Home & Future Roles
The Role of the Diabetes Educator within the Patient-Centered Medical Home & Future Roles Linda M. Siminerio, RN, PhD, CDE Professor of Medicine University of Pittsburgh School of Medicine & Nursing Objectives
More informationImpact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients
2012 International Conference on Life Science and Engineering IPCBEE vol.45 (2012) (2012) IACSIT Press, Singapore DOI: 10.7763/IPCBEE. 2012. V45. 14 Impact of Physical Activity on Metabolic Change in Type
More informationKey Elements in Managing Diabetes
Key Elements in Managing Diabetes Presentor Disclosure No conflicts of interest to disclose Presented by Susan Cotey, RN, CDE Lennon Diabetes Center Stephanie Tubbs Jones Health Center Cleveland Clinic
More informationSerum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic
Supplementary Information The title of the manuscript Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke Xin-Wei He 1, Wei-Ling Li 1, Cai Li
More informationStatin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography
Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography Hyo Eun Park 1, Eun-Ju Chun 2, Sang-Il Choi 2, Soyeon Ahn 2, Hyung-Kwan Kim 3,
More informationWelcome and Introduction
Welcome and Introduction This presentation will: Define obesity, prediabetes, and diabetes Discuss the diagnoses and management of obesity, prediabetes, and diabetes Explain the early risk factors for
More informationClinical Study Synopsis
Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace
More informationDisclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease
Disclosures Diabetes and Cardiovascular Risk Management Tony Hampton, MD, MBA Medical Director Advocate Aurora Operating System Advocate Aurora Healthcare Downers Grove, IL No conflicts or disclosures
More informationText-based Document. Psychometric Evaluation of the Diabetes Self-Management Instrument-Short Form (DSMI-20) Lin, Chiu-Chu; Lee, Chia-Lun
The Henderson Repository is a free resource of the Honor Society of Nursing, Sigma Theta Tau International. It is dedicated to the dissemination of nursing research, researchrelated, and evidence-based
More informationTest5, Here is Your My5 to Health Profile with Metabolic Syndrome Insight
Test5, Here is Your My5 to Health Profile with Metabolic Syndrome Insight Quest, Quest Diagnostics, the associated logo, and all associated Quest Diagnostics marks are the registered trademarks of Quest
More informationPrevalence of diabetes and impaired fasting glucose in Uygur children of Xinjiang, China
Prevalence of diabetes and impaired fasting glucose in Uygur children of Xinjiang, China J. Zhang 1, Y.T. Ma 1, X. Xie 1, Y.N. Yang 1, F. Liu 2, X.M. Li 1, Z.Y. Fu 1, X. Ma 1, B.D. Chen 2, Y.Y. Zheng 1,
More informationTreatment guideline for adult patients with type 1 diabetes?
Treatment guideline for adult patients with type 1 diabetes? Jae Hyeon Kim Division of Endocrinology and Metabolism, Samsung Medical Center, Sungkyunkwan University School of Medicine ICDM 2014 Treatment
More informationDiabetes Self-Management Education and Support (DSMES) Accreditation/Recognition 101
Diabetes Self-Management Education and Support (DSMES) Accreditation/Recognition 101 What is DSMES? Diabetes Self-Management Education and Support (DSMES) Evidence-based intervention that strengthens the
More informationNon-insulin treatment in Type 1 DM Sang Yong Kim
Non-insulin treatment in Type 1 DM Sang Yong Kim Chosun University Hospital Conflict of interest disclosure None Committee of Scientific Affairs Committee of Scientific Affairs Insulin therapy is the mainstay
More informationDiabetes Mellitus: A Cardiovascular Disease
Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular
More informationChanges and clinical significance of serum vaspin levels in patients with type 2 diabetes
Changes and clinical significance of serum vaspin levels in patients with type 2 diabetes L. Yang*, S.J. Chen*, G.Y. Yuan, D. Wang and J.J. Chen Department of Endocrinology, Affiliated Hospital of Jiangsu
More informationOne year outcomes of Type 2 Diabetes Mellitus Patients after an Integrated Patient Care Plan (IPCP) Presented by APN Ng Sau Yee NTW Diabetes Centre
One year outcomes of Type 2 Diabetes Mellitus Patients after an Integrated Patient Care Plan (IPCP) Presented by APN Ng Sau Yee NTW Diabetes Centre Background No endocrine team in NTWC before 2003 Great
More informationKnow Your Number Aggregate Report Single Analysis Compared to National Averages
Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics
More informationElevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with
Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with Insulin Resistance Mehrnoosh Shanaki, Ph.D. Assistant Professor of Clinical Biochemistry Shahid Beheshti
More informationMetabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology
Metabolic Syndrome Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Disclosure No conflict of interest No financial disclosure Does This Patient Have Metabolic Syndrome? 1. Yes 2. No Does This Patient
More informationPresenter Disclosure
Presenter Disclosure Linong Ji.M.D Consulting and lecture fee Eli Lilly, Bristol-Myers Squibb, Novartis, Novo Nordisk, Merck, Bayer, Takeda, Sanofi-Aventis, GlaxoSmithKline, Roche, Johnson & Johnson, boehinger
More informationIf DSME* were a pill, would you prescribe it?
If DSME* were a pill, would you prescribe it? *Diabetes Self-Management Education/Training Jan Kincaid Rystrom, RD CDE MEd Manager, Diabetes Education EvergreenHealth Goals Evaluate DSME as part of ADA
More informationCorrelation between fasting insulin and blood pressure in obese and non-obese middle aged Indian diabetic adults
Volume: 2, Issue: 5, 241-245 May 2015 www.allsubjectjournal.com e-issn: 2349-4182 p-issn: 2349-5979 Impact Factor: 3.762 Raja Reddy P Assistant professor, Department of Physiology, Sri Devaraj Urs Medical
More informationJanice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES
Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES Objectives u At conclusion of the lecture the participant will be able to: 1. Differentiate between the classifications of diabetes
More informationClinical Practice Guideline Key Points
Clinical Practice Guideline Key Points Clinical Practice Guideline 2008 Key Points Diabetes Mellitus Provided by: Highmark Endocrinology Clinical Quality Improvement Committee In accordance with Highmark
More informationA pilot Study of 25-Hydroxy Vitamin D in Egyptian Diabetic Patients with Diabetic Retinopathy
A pilot Study of 25-Hydroxy Vitamin D in Egyptian Diabetic Patients with Diabetic Retinopathy El-Orabi HA 1, Halawa MR 1, Abd El-Salam MM 1, Eliewa TF 2 and Sherif NSE 1 Internal Medicine and Endocrinology
More informationPatient is healthy with no chronic disease or significant risk factors [16%].
AAFP Risk Level 1 Patient is healthy with no chronic disease or significant risk factors [16%]. Exclude the following chronic problems from active patient list o Depression o Diabetes Type I or Type II
More informationTo reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees.
E Nancy A. Haller, MPH, CHES, Manager, State Wellness Program M PLOYEES To reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees. To suspend or decrease the rising costs
More informationIt Happens Even in Type 2! When to Start Thinking Seriously About Hypoglycemia
It Happens Even in Type 2! When to Start Thinking Seriously About Hypoglycemia Jacqueline LaManna, PhD, ANP BC, BC ADM, CDE Holly Divine, PharmD, BCACP, CGP, CDE, FAPhA Disclosures Dr. Jacqueline LaManna
More informationEffectiveness of a Multidisciplinary Patient Assistance Program in Diabetes Care
University of Rhode Island DigitalCommons@URI Senior Honors Projects Honors Program at the University of Rhode Island 2009 Effectiveness of a Multidisciplinary Patient Assistance Program in Diabetes Care
More informationSCIENTIFIC STUDY REPORT
PAGE 1 18-NOV-2016 SCIENTIFIC STUDY REPORT Study Title: Real-Life Effectiveness and Care Patterns of Diabetes Management The RECAP-DM Study 1 EXECUTIVE SUMMARY Introduction: Despite the well-established
More informationChapter 3 - Does Low Well-being Modify the Effects of
Chapter 3 - Does Low Well-being Modify the Effects of PRISMA (Dutch DESMOND), a Structured Selfmanagement-education Program for People with Type 2 Diabetes? Published as: van Vugt M, de Wit M, Bader S,
More informationResearch Article Associated Factors with Biochemical Hypoglycemia during an Oral Glucose Tolerance Test in a Chinese Population
Hindawi Diabetes Research Volume 2017, Article ID 3212814, 5 pages https://doi.org/10.1155/2017/3212814 Research Article Associated Factors with Biochemical Hypoglycemia during an Oral Glucose Tolerance
More informationImprovement on Outcomes of Overweight Type 2 Diabetics after an Enhanced Disease Management Programme
Improvement on Outcomes of Overweight Type 2 Diabetics after an Enhanced Disease Management Programme Presented by APN Ng Sau Yee NTW Diabetes Centre Background Target group: Overweight Type 2 Diabetics
More informationfor the Management of Chronic Disease
Patient-Centred Care Approaches for the Management of Chronic Disease Anna Chapman Research Fellow RDNS Institute Overview of Presentation Burden Second of level Disease in Australia Chronic Disease Management
More informationCARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES
CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES C. Liakos, 1 G. Vyssoulis, 1 E. Karpanou, 2 S-M. Kyvelou, 1 V. Tzamou, 1 A. Michaelides, 1 A. Triantafyllou, 1 P. Spanos, 1 C. Stefanadis
More informationDiagnosis and Management of Type 2 Diabetes Mellitus in Adults
Quality Improvement Support: Diagnosis and Management of Type 2 Diabetes Mellitus in Adults The Aims and Measures section is intended to provide guideline users with a menu of measures for multiple purposes,
More informationNutrition Care Process. Catherine Villafranca & Anthony Richitt
Nutrition Care Process Catherine Villafranca & Anthony Richitt Nutrition Care Process -According to eatrightpro.org, the Nutrition Care Process is a systematic approach to providing high-quality nutrition
More informationSugar Smart for Life Diabetes Prevention To Go
Sugar Smart for Life Diabetes Prevention To Go Margaret Prinzavalli Sotham Director, Community Health Strategy West Kendall Baptist Hospital Edwin Rivera Chief Evangelist LifeWallet, LLC West Kendall Baptist
More informationPREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS
PREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS Mehmet Emre Atabek,MD,PhD Necmettin Erbakan University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology and
More informationScreening and Diagnosis of Diabetes Mellitus in Taiwan
Screening and Diagnosis of Diabetes Mellitus in Taiwan Hung-Yuan Li, MD, MMSc, PhD Attending Physician, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan Associate Professor,
More informationThe Diabetes Link to Heart Disease
The Diabetes Link to Heart Disease Anthony Abe DeSantis, MD September 18, 2015 University of WA Division of Metabolism, Endocrinology and Nutrition Oswald Toosweet Case #1 68 yo M with T2DM Diagnosed DM
More informationImpact of diabetes education and peer support group on the metabolic parameters of patients with Diabetes Mellitus (Type 1 and Type 2)
BJMP 2013;6(4):a635 Research Article Impact of diabetes education and peer support group on the metabolic parameters of patients with Diabetes Mellitus (Type 1 and Type 2) Issac Sachmechi, Aileen Wang,
More informationDiabetes Day for Primary Care Clinicians Advances in Diabetes Care
Diabetes Day for Primary Care Clinicians Advances in Diabetes Care Elliot Sternthal, MD, FACP, FACE Chair New England AACE Diabetes Day Planning Committee Welcome and Introduction This presentation will:
More informationCARE PATHWAYS. Allyson Ashley
CARE PATHWAYS Allyson Ashley WHAT IS A CARE PATHWAY? An explicit statement of the goals and key elements of care based on evidence, best practice, and patient s expectations and their characteristics The
More informationMetabolic Syndrome in Asians
Metabolic Syndrome in Asians Alka Kanaya, MD Asst. Professor of Medicine, UCSF Asian CV Symposium, November 17, 2007 The Metabolic Syndrome Also known as: Syndrome X Insulin Resistance Syndrome The Deadly
More informationDonna Amundson, RN, BSN, CDE Director of the Sanford Diabetes Center Bismarck, ND
Donna Amundson, RN, BSN, CDE Director of the Sanford Diabetes Center Bismarck, ND Discuss the core principles of quality management for diabetes care and education Identify the 6 core elements of the Chronic
More informationEffects of Bariatric Surgery in Obese Patients with Hypertension The GATEWAY Randomized Trial
Effects of Bariatric Surgery in Obese Patients with Hypertension The GATEWAY Randomized Trial Carlos Aurelio Schiavon, MD, FACS On behalf of the GATEWAY Executive Committee and Investigators DISCLOSURE
More information2010 ADA Guidelines: 1. Diagnostic Criteria for DM 2. Categories of increased risk of DM. Gerti Tashko, M.D. DM Journal Club 1/21/2010
2010 ADA Guidelines: 1. Diagnostic Criteria for DM 2. Categories of increased risk of DM Gerti Tashko, M.D. DM Journal Club 1/21/2010 NEW: Diagnosis with A1c 6.5% Cut point of A1c 6.5% diagnoses 33% less
More informationA Summary Report: 2003
D iabetes in Idaho A Summary Report: 2003 Idaho Department of Health and Welfare Division of Health Bureau of Community and Environmental Health This publication was supported by Grant No. U32/CCU022691-02
More informationIs Knowing Half the Battle? Behavioral Responses to Risk Information from the National Health Screening Program in Korea
Is Knowing Half the Battle? Behavioral Responses to Risk Information from the National Health Screening Program in Korea Hyuncheol Bryant Kim 1, Suejin A. Lee 1, and Wilfredo Lim 2 1 Cornell University
More informationScreening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016
Juniata College Screening Results Juniata College Screening Results October 11, 2016 & October 12, 2016 JUNIATA COLLEGE The J.C. Blair Hospital CARES team screened 55 Juniata College employees on October
More informationTotal risk management of Cardiovascular diseases Nobuhiro Yamada
Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible
More information2017 Employee Wellness Health Assessment Report
Employee Wellness National Consortium for Building Healthy Academic Communities (BHAC) Healthier Tennessee Workplace 2017 Employee Wellness Health Assessment Report Blood Pressure 2017 (387 total) (National
More informationVipul Lakhani, MD Oregon Medical Group Endocrinology
Vipul Lakhani, MD Oregon Medical Group Endocrinology Disclosures None Objectives Be able to diagnose diabetes and assess control Be able to identify appropriate classes of medications for diabetes treatment
More informationClient Report Screening Program Results For: Missouri Western State University October 28, 2013
Client Report For: Missouri Western State University October 28, 2013 Executive Summary PROGRAM OVERVIEW From 1/1/2013-9/30/2013, Missouri Western State University participants participated in a screening
More informationUnraveling the concealed and calculated cardiovascular risks in diabetes
15 P B Fernando Memorial Oration 2015 Unraveling the concealed and calculated cardiovascular risks in diabetes Weerarathna T P 1 Journal of the Ceylon College of Physicians, 2016, 47, 15-19 Abstract Cardiovascular
More informationComparing the use of SMBG vs. CGM data to Optimize Glucose Control in T2DM
Comparing the use of SMBG vs. CGM data to Optimize Glucose Control in T2DM For the first time using CGM to assess glucose control achieved in both groups Richard M. Bergenstal, MD International Diabetes
More informationEffects of Bariatric Surgery in Obese Patients with Hypertension The GATEWAY Randomized Trial
Effects of Bariatric Surgery in Obese Patients with Hypertension The GATEWAY Randomized Trial Carlos Aurelio Schiavon, MD, FACS On behalf of the GATEWAY Executive Committee and Investigators DISCLOSURE
More informationRole of SMBG in Non-Insulin Treated Subjects with T2DM Richard M. Bergenstal, MD
Role of SMBG in Non-Insulin Treated Subjects with T2DM Richard M. Bergenstal, MD International Diabetes Center and Health Services University of Minnesota Minneapolis, MN richard.bergenstal@parknicollet.com
More informationGATEWAY Trial. Bariatric Surgery versus Conventional Medical Treatment in Obese Patients with Hypertension
GATEWAY Trial Bariatric Surgery versus Conventional Medical Treatment in Obese Patients with Hypertension Carlos Aurelio Schiavon, MD, FACS On behalf of the GATEWAY Executive Committee and Investigators
More informationDMEP Study Section 1 1
DMEP Study Section 1 1 1. EXECUTIVE SUMMARY 1.1 Objectives The specific aims of the Diabetes Mellitus Education Program (DMEP) were to examine the role of the community pharmacist in the disease state
More informationFigure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution
Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein
More informationPromotive effect of comprehensive management on achieving blood glucose control in senile type 2 diabetics
Promotive effect of comprehensive management on achieving blood glucose control in senile type 2 diabetics S.-T. Yan, C.-X. Li, C.-L. Li, J. Li, Y.-H. Shao, Y. Liu, W.-W. Zhong, F.-S. Fang, B.-R. Sun and
More informationSponsor / Company: Sanofi Drug substance(s): Insulin Glargine. Study Identifiers: NCT
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription. Sponsor / Company: Sanofi Drug substance(s):
More informationprogramme. The DE-PLAN follow up.
What are the long term results and determinants of outcomes in primary health care diabetes prevention programme. The DE-PLAN follow up. Aleksandra Gilis-Januszewska, Noël C Barengo, Jaana Lindström, Ewa
More informationRehabilitation and Research Training Center on Secondary Conditions in Individuals with SCI. James S. Krause, PhD
Disclosure The contents of this presentation were developed with support from educational grants from the Department of Education, NIDRR grant numbers H133B090005, H133B970011 and H133G010160. However,
More informationDiabetes: Everything You Want to Know. LCDR Bernadine John, RN, BSN, CDE
Diabetes: Everything You Want to Know LCDR Bernadine John, RN, BSN, CDE I have no financial affiliation to disclose as a conflict of interest regarding this presentation. DM Standards of Care The IHS Division
More informationImproving Quality in Type 2 Diabetes:
Improving Quality in Type 2 Diabetes: Reengineering Practices From the Inside The Endocrine Society / The Hormone Foundation American Pharmacists Association Opus Science, LLC Presenters / Disclosures
More informationUtah Diabetes Practice Recommendations Diabetes Management for Adults
Utah Diabetes Practice Recommendations Diabetes Management for Adults 2011 Panel Sarah Woolsey, MD, Chair, Family Medicine HealthInsight Wayne Cannon, MD, Pediatrics Intermountain Healthcare Roy Gandolfi,
More informationBariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic Patients: 3-Year Outcomes
Bariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic Patients: 3-Year Outcomes Results of the STAMPEDE Trial Philip R Schauer, Deepak L Bhatt, John P Kirwan, Kathy Wolski, Stacy A Brethauer,
More informationTRIple pill vs. Usual care Management for Patients with mild-to-moderate Hypertension
TRIple pill vs. Usual care Management for Patients with mild-to-moderate Hypertension The TRIUMPH study Dr Ruth Webster, PhD, MBBS, MIPH, BMedSc Global control rates for hypertension BP < 140/90 among
More informationPresenter Disclosure Information
Prediabetes & Type 2 Diabetes Prevention Cari Ritter, PA-C Presenter Disclosure Information In compliance with the accrediting board policies, the American Diabetes Association requires the following disclosure
More informationHbA1c is associated with intima media thickness in individuals with normal glucose tolerance
Diabetes Care Publish Ahead of Print, published online October 6, 2009 Glucose metabolism and IMT HbA1c is associated with intima media thickness in individuals with normal glucose tolerance Thomas Bobbert,
More informationInterventions: Improving & Impacting Outcomes in Weight & Diabetes Issues. JoAnn Franklin, APRN, FNP-BC, GNP-BC, MHNP Doctor of Nursing Practice
AS Interventions: Improving & Impacting Outcomes in Weight & Diabetes Issues JoAnn Franklin, APRN, FNP-BC, GNP-BC, MHNP Doctor of Nursing Practice Since 1991 a direct correlation between Diabetes type
More information= AUDIO. Managing Diabetes for Improved Cardiovascular Health. An Important Reminder. Mission of OFMQ 8/18/2015. Jimmi Norris MS, RN, CDE
Managing Diabetes for Improved Cardiovascular Health Jimmi Norris MS, RN, CDE An Important Reminder For audio, you must use your phone: Step 1: Call (866) 906 0123. Step 2: Enter code 2071585#. Step 3:
More informationAddressing Addressing Challenges in Type 2 Challenges in Type 2 Diabetes Diabetes Speaker:
Addressing Challenges in Type 2 Diabetes Geneva Briggs, PharmD,, BCPS Addressing Challenges in Type 2 Diabetes Speaker: Dr. Geneva Clark Briggs, a board-certified Pharmacotherapy Specialist, received her
More informationCHALLENGING CASE PRESENTATION Steroid Induced Hyperglycemia
CHALLENGING CASE PRESENTATION Steroid Induced Hyperglycemia Javier Carrasco, MD, PhD Juan Ramón Jiménez Hospital University of Huelva, Spain Case Study: Medical and Social History A 60 years old female
More informationDiabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable?
Diabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable? Jay S. Skyler, MD, MACP Division of Endocrinology, Diabetes, and Metabolism and Diabetes Research Institute University of
More informationDiabetes and New Meds for Cardiovascular Risk Reduction. F. Dwight Chrisman, MD, FACC. Disclosures: BI Boehringer Ingelheim speaker
Diabetes and New Meds for Cardiovascular Risk Reduction F. Dwight Chrisman, MD, FACC Disclosures: BI Boehringer Ingelheim speaker 1 Prevalence of DM DM state specific prevalence 2006 4%-6% 6-8% 8-10% 10-12%
More informationAnalysis Plan Submission Form
Analysis Plan Submission Form DMHT : Analysis Plan #00410222 Date submitted: 03 January 2014 at 15:19:09 Date approved: Analysis Plan Title: Achievement of metabolic goals among different health insurance
More informationInsomnia and Health- Related Quality of Life in Adults with Type 2 Diabetes
Insomnia and Health- Related Quality of Life in Adults with Type 2 Diabetes Eileen R. Chasens, PhD, RN, FAAN Letitia Y. Graves, MSN Susan M. Sereika, PhD University of Pittsburgh Conflicts of interest
More informationLEPTIN AS A NOVEL PREDICTOR OF DEPRESSION IN PATIENTS WITH THE METABOLIC SYNDROME
LEPTIN AS A NOVEL PREDICTOR OF DEPRESSION IN PATIENTS WITH THE METABOLIC SYNDROME Diana A. Chirinos, Ronald Goldberg, Elias Querales-Mago, Miriam Gutt, Judith R. McCalla, Marc Gellman and Neil Schneiderman
More informationRISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES
RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES Risk Factors or Complications Glycemic Control Fasting & Capillary Plasma Glucose Anti-platelet
More informationDepok-Indonesia STEPS Survey 2003
The STEPS survey of chronic disease risk factors in Indonesia/Depok was carried out from February 2003 to March 2003. Indonesia/Depok carried out Step 1, Step 2 and Step 3. Socio demographic and behavioural
More informationNomogram of the Relation of Brachial-Ankle Pulse Wave Velocity with Blood Pressure
801 Original Article Nomogram of the Relation of Brachial-Ankle Pulse Wave Velocity with Blood Pressure Akira YAMASHINA, Hirofumi TOMIYAMA, Tomio ARAI, Yutaka KOJI, Minoru YAMBE, Hiroaki MOTOBE, Zydem
More informationObesity Prevention and Control: Provider Education with Patient Intervention
Obesity Prevention and : Provider Education with Patient Summary Evidence Table and Population Cohen et al. (1991) 1987-1988 : RCT Location: Pittsburgh, PA Physician training session by a behavioral psychologist
More informationText-based Document. Predicting Factors of Body Fat of Metabolic Syndrome Persons. Downloaded 13-May :51:47.
The Henderson Repository is a free resource of the Honor Society of Nursing, Sigma Theta Tau International. It is dedicated to the dissemination of nursing research, researchrelated, and evidence-based
More informationMetabolic Syndrome: A Preventable & Treatable Cluster of Conditions
Metabolic Syndrome: A Preventable & Treatable Cluster of Conditions April D. McNeill MD Candidate 2016, Southern Illinois University, School of Medicine GE-NMF Primary Care Leadership Program, July 2013
More informationType 2 Diabetes Mellitus in Adolescents PHIL ZEITLER MD, PHD SECTION OF ENDOCRINOLOGY DEPARTMENT OF PEDIATRICS UNIVERSITY OF COLORADO DENVER
Type 2 Diabetes Mellitus in Adolescents PHIL ZEITLER MD, PHD SECTION OF ENDOCRINOLOGY DEPARTMENT OF PEDIATRICS UNIVERSITY OF COLORADO DENVER Yes! Is Type 2 diabetes the same in kids as in adults? And No!
More informationRisk Assessment of developing type 2 diabetes mellitus in patient on antihypertensive medication
41 Research Article Risk Assessment of developing type 2 diabetes mellitus in patient on antihypertensive medication Amarjeet Singh*, Sudeep bhardwaj, Ashutosh aggarwal Department of Pharmacology, Seth
More informationPrevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus patients in a tertiary care hospital of Bihar
Original Research Article Prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus patients in a tertiary care hospital of Bihar Naresh Kumar 1, Jyoti Kumar Dinkar 2*, Chandrakishore
More informationHypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents
Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Stella Stabouli Ass. Professor Pediatrics 1 st Department of Pediatrics Hippocratio Hospital Evaluation of
More information(a) y = 1.0x + 0.0; r = ; N = 60 (b) y = 1.0x + 0.0; r = ; N = Lot 1, Li-heparin whole blood, HbA1c (%)
cobas b system - performance evaluation Study report from a multicenter evaluation of the new cobas b system for the measurement of HbAc and lipid panel Introduction The new cobas b system provides a point-of-care
More informationAssociation between arterial stiffness and cardiovascular risk factors in a pediatric population
+ Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro
More informationTable S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416).
Table S1. Characteristics associated with frequency of nut (full entire sample; Nn=4,416). Daily nut Nn= 212 Weekly nut Nn= 487 Monthly nut Nn= 1,276 Infrequent or never nut Nn= 2,441 Sex; n (%) men 52
More informationPrevalence of Comorbidities among HIV-positive patients in Taiwan
Prevalence of Comorbidities among HIV-positive patients in Taiwan Chien-Ching Hung, MD, PhD Department of Internal Medicine National Taiwan University Hospital, Taipei, Taiwan % of participants Comorbidity
More informationDiabetes Mellitus: Implications of New Clinical Trials and New Medications
Diabetes Mellitus: Implications of New Clinical Trials and New Medications Estimates of Diagnosed Diabetes in Adults, 2005 Alka M. Kanaya, MD Asst. Professor of Medicine UCSF, Primary Care CME October
More informationDM type. Diagnostic method of DR. fluorescein angiography; Ophthalmoscopy. ophthalmoscopic examination. fundus photography; Ophthalmoscopy
2012 Informa USA, Inc. DOI: 10.3109/13816810.2012.675398 Online supplementary material published in conjunction with S. Zhao et al.., Nitric oxide synthase 3 (NOS3) 4b/a, T-786C and G894T polymorphisms
More informationGuideline for Management of Type 2 Diabetes Mellitus: Kingdome of Bahrain Ministry of Health 2016
Guideline for Management of Type 2 Diabetes Mellitus: Kingdome of Bahrain Ministry of Health 2016 1. Screening and diagnosis: Detection type 2 Diabetes are usually based on a two-step approach: Step 1:
More information